Latest news with #ShinichiroMuraoka
Business Insider
3 days ago
- Business
- Business Insider
Morgan Stanley Keeps Their Hold Rating on SanBio Co (SNBIF)
In a report released on May 29, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on SanBio Co (SNBIF – Research Report), with a price target of Yen1,400.00. Confident Investing Starts Here: Muraoka covers the Healthcare sector, focusing on stocks such as SanBio Co, Astellas Pharma, and Daiichi Sankyo Company. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Sell analyst consensus rating for SanBio Co with a $5.83 average price target. Based on SanBio Co's latest earnings release for the quarter ending January 31, the company reported a quarterly GAAP net loss of $730.52 million. In comparison, last year the company had a GAAP net loss of $761.28 million
Business Insider
3 days ago
- Business
- Business Insider
Morgan Stanley Sticks to Their Hold Rating for Eisai Co (ESALF)
In a report released on May 29, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on Eisai Co (ESALF – Research Report), with a price target of Yen4,100.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Muraoka covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Daiichi Sankyo Company, and Eisai Co. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks. In addition to Morgan Stanley, Eisai Co also received a Hold from Jefferies's Stephen Barker in a report issued yesterday. However, on May 15, Bernstein maintained a Buy rating on Eisai Co (Other OTC: ESALF).
Business Insider
3 days ago
- Business
- Business Insider
Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)
Morgan Stanley analyst Shinichiro Muraoka maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen4,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Muraoka covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Daiichi Sankyo Company, and Shionogi & Co. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a Yen4,700.00 price target.
Business Insider
3 days ago
- Business
- Business Insider
Morgan Stanley Sticks to Its Hold Rating for Astellas Pharma (ALPMF)
In a report released yesterday, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on Astellas Pharma (ALPMF – Research Report), with a price target of Yen1,500.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Muraoka is an analyst with an average return of -3.9% and a 33.33% success rate. Muraoka covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Shionogi & Co, and SanBio Co. Astellas Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $12.15.
Business Insider
3 days ago
- Business
- Business Insider
Morgan Stanley Keeps Their Hold Rating on Shionogi & Co (SGIOF)
In a report released yesterday, Shinichiro Muraoka from Morgan Stanley maintained a Hold rating on Shionogi & Co (SGIOF – Research Report), with a price target of Yen2,750.00. The company's shares closed last Wednesday at $15.20. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Muraoka is an analyst with an average return of -3.9% and a 33.33% success rate. Muraoka covers the Healthcare sector, focusing on stocks such as Shionogi & Co, SanBio Co, and Takeda Pharmaceutical Co. The word on The Street in general, suggests a Hold analyst consensus rating for Shionogi & Co with a $15.75 average price target. SGIOF market cap is currently $14.58B and has a P/E ratio of 11.57.
